Drug industry writers propose code of ethical conductBMJ 2002; 324 doi: http://dx.doi.org/10.1136/bmj.324.7341.808/e (Published 06 April 2002) Cite this as: BMJ 2002;324:808
- Gavin Yamey
A group of pharmaceutical industry writers is urging all drug companies to adopt a new code of conduct that gives guidance on ethical publication practice.
The code, called Good Publication Practice for Pharmaceutical Companies, includes a commitment to register and publish all trials and to avoid redundant or duplicate publication.
The code was discussed at last week's …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial